Published on 16 October 2020

COVID-19 vaccine: Swiss federal government signs agreement with AstraZeneca

Berne, 16.10.2020 - The Swiss federal government wants to assure members of the Swiss public rapid access to COVID-19 vaccines. Given that it is still not clear which vaccines will ultimately prevail, the government is taking a diversified approach. It has now signed an agreement with UK pharmaceuticals company AstraZeneca and the Swedish government for the delivery of up to 5.3 million doses of vaccine. The Swiss public will therefore gain access to a further COVID-19 vaccine – provided it successfully passes the clinical trial phase and is approved by Swissmedic.